Thrombin generation assays for optimizing low molecular weight heparin dosing in pregnant women at risk of thrombosis--response to Ismail et al

Br J Haematol. 2016 Feb;172(4):643-4. doi: 10.1111/bjh.13523. Epub 2015 Jun 3.

Authors

Pratima Chowdary¹, Anne Riddell², Collen Hamid², Alex Gatt^{2

3}

Affiliations

¹ Katharine Dormandy Haemophilia Centre and Thrombosis Unit, Royal Free Hospital, London, UK. p.chowdary@nhs.net.
² Katharine Dormandy Haemophilia Centre and Thrombosis Unit, Royal Free Hospital, London, UK.
³ Department of Haemato-Oncology, Mater Dei Hospital, Msida, Malta.

PMID: 26036455
DOI: 10.1111/bjh.13523

No abstract available

Keywords: anti-Xa; heparin; pregnancy; thrombin generation assay.

Publication types

Letter
Comment

MeSH terms

Anticoagulants*
Factor Xa Inhibitors / blood*
Female
Heparin, Low-Molecular-Weight*
Humans
Monitoring, Physiologic*
Pregnancy
Pregnancy Complications, Hematologic*
Thrombophilia*

Substances

Anticoagulants
Factor Xa Inhibitors
Heparin, Low-Molecular-Weight